Comparing Belsomra vs Dayvigo
Belsomra | Dayvigo |
|
---|
Belsomra (suvorexant) | Dayvigo (lemborexant) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Insomnia. Belsomra may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Insomnia. Dayvigo may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||
More about Belsomra (suvorexant) | More about Dayvigo (lemborexant) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Belsomra has an average rating of 3.7 out of 10 from a total of 532 ratings on Drugs.com. 26% of reviewers reported a positive effect, while 63% reported a negative effect. |
Dayvigo has an average rating of 4.9 out of 10 from a total of 257 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 49% reported a negative effect. |
||||||||||||||||
Drug Class | |||||||||||||||||
Side Effects | |||||||||||||||||
See also: Belsomra side effects in more detail. |
See also: Dayvigo side effects in more detail. |
||||||||||||||||
Generic Availability | |||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Belsomra prices |
View all Dayvigo prices |
||||||||||||||||
Dosage Forms Available | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
12 hours |
19 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | |||||||||||||||||
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 477 drugs are known to interact with Belsomra:
|
A total of 427 drugs are known to interact with Dayvigo:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
August 13, 2014 |
December 20, 2019 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.